Daikenchuto vs control
Any drug‐related adverse events (CTCAE grade ≥ 2)
Daikenchuto showed no clear difference in any drug‐related adverse events (CTCAE grade ≥ 2) compared with control (low certainty).
1 finding from 1 review
- Daikenchuto for reducing postoperative ileus in patients undergoing elective abdominal surgery 2018 · Cochrane Headline outcomes onlyRD 05 studies · 568 participantsLow